Intracytoplasmic sperm injection

Beverly Hills Based IMA ART Fertility Launches We Create Heirs Marketing Campaign Serving China's Uber-Wealthy

Retrieved on: 
Thursday, August 17, 2023
PGT, LGBTQ, Parent, IMA, ART, Single person, Fertility, Risk, Child, ICSI, Genetic testing, Imagination, Family, Intracytoplasmic sperm injection, Andrew Kerr (festival co-founder), Birth control

IMA ART Fertility helps its Chinese Clientele create the next generation through access to the world's finest network of specialists in the fields of fertility and reproductive law.

Key Points: 
  • IMA ART Fertility helps its Chinese Clientele create the next generation through access to the world's finest network of specialists in the fields of fertility and reproductive law.
  • Launching the first of its kind We Create Heirs(R) fertility & surrogacy campaign exclusively serving China's super wealthy, IMA ART embarks upon a truly unique adventure to capture the senses, imagination and desires of discreet high-net-worth families.
  • IMA ART redefined a new paradigm in fertility," said Michelle Tang, CEO, Co-Founder & Ethnic Chinese.
  • Unfortunately, for many, this ultimate luxury requires a little help - that's where IMA ART Fertility's bespoke family journey comes in.

Insights on the Micromanipulators Global Market to 2028 - Increasing Success Rate of IVF Technology is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, November 28, 2022
Health, Biotechnology, Mental health, IVF, Micromanipulator, Glass, Intracytoplasmic sperm injection, Movement, Travel, Birth, ART, Family, Research, Woman, Application, Infertility, Pregnancy, Physics, Egg, Microscope, Birth control

The Global Micromanipulators Market size is expected to reach $12.8 million by 2028, rising at a market growth of 4.4% CAGR during the forecast period.

Key Points: 
  • The Global Micromanipulators Market size is expected to reach $12.8 million by 2028, rising at a market growth of 4.4% CAGR during the forecast period.
  • In addition, micromanipulators are also utilized in biological research and microelectronics to position test probes onto tiny to medium scale integrated circuits and hybrid devices.
  • To provide coarse and fine placement, mechanisms with distinct ranges of movement or variable reduction ratios may be combined in one instrument.
  • IVF success rates have risen in recent years, especially among older women, which is encouraging for people who want to establish a family through IVF.

Matan Yemini is recognized by Continental Who's Who

Retrieved on: 
Friday, January 28, 2022
Diamond, Fertility preservation, Intracytoplasmic sperm injection, Patient, Indian Diamond Institute, Weizmann Institute of Science, Tel Aviv, Distinguishing, Kaplan Medical Center, Physician, Program, ICSI, Continental, Embryology, Gynaecology, Male, Research, Laboratory, Reproduction, Medicine, Reproductive medicine, Medical school, Infertility, IVF, Pregnancy, Paola Lattus, Time, Division, Leonard M. Miller School of Medicine, Multimedia, Private practice, GLMA, Partner, Menopause, Birth control, Medical device, Obstetrics, Diagnosis

MILBURN, N.J., Jan. 28, 2022 /PRNewswire/ -- Matan Yemini is being recognized by Continental Who's Who as a Distinguished Infertility Specialist in the Medical field and in acknowledgment of his work at Diamond Institute for Infertility and Menopause.

Key Points: 
  • MILBURN, N.J., Jan. 28, 2022 /PRNewswire/ -- Matan Yemini is being recognized by Continental Who's Who as a Distinguished Infertility Specialist in the Medical field and in acknowledgment of his work at Diamond Institute for Infertility and Menopause.
  • Dr. Yemini is one of two physicians at the Diamond Institute for Infertility and Menopause.
  • Dr. Yemini first attended Jerusalem's Hadassah Hebrew University School of Medicine, graduating in 1978.
  • During that time, Dr. Yemini furthered his training with Reproductive Endocrinology at Kaplan Medical Center's Division of Reproductive Medicine.

CES 2021 Taiwanese Startup iPreg's Sperm Sorting Chip is the Game-Changer in IVF Market

Retrieved on: 
Tuesday, January 12, 2021
Fertility medicine, Human reproduction, Reproduction, Behavior, Human pregnancy, Obstetrics, Fertility, Sperm sorting, Intracytoplasmic sperm injection, In vitro fertilisation, Fertilisation, Sperm bank

Its main services focus on in vitro fertilization market and continuously improve the new generation of sperm sorting methods.

Key Points: 
  • Its main services focus on in vitro fertilization market and continuously improve the new generation of sperm sorting methods.
  • One of the weaknesses of IVF is inefficient sperm selection with the traditional sperm sorting processes.
  • The iPreg Sperm Sorting Chip has proven the ability to increase the healthy sperm ratio to 90% in 15 minutes, therefore, it plays a role in assisting reproduction that accelerates the crucial stage of sperm screening in IVF.
  • iPreg Sperm Sorting Chip's performance in efficiency, safety, and quality could be the crucial piece of the puzzle in the stages of the IVF process.

Ohana Biosciences Presents New Data in Mouse ICSI Study Demonstrating That Ohana Sperm Cell Treatment Improves Embryo Development at ASRM Virtual Scientific Congress and Expo

Retrieved on: 
Tuesday, October 20, 2020
Research, MEN, Consumer, Genetics, Parenting, Clinical trials, Science, Baby, Maternity, Women, Biotechnology, Other Science, Health, Human reproduction, Fertility, Reproduction, Branches of biology, Assisted reproductive technology, Semen, In vitro fertilisation, Sperm, Fertilisation, Intracytoplasmic sperm injection, Acrosome reaction

These data will be presented today during a poster presentation at the 76th American Society for Reproductive Medicine (ASRM) Virtual Scientific Congress and Expo.

Key Points: 
  • These data will be presented today during a poster presentation at the 76th American Society for Reproductive Medicine (ASRM) Virtual Scientific Congress and Expo.
  • The ASRM poster presentation includes data from a preclinical study in a mouse model of ICSI in vitro fertilization (IVF), which was designed to measure the impact of the Ohana sperm cell treatment on embryo development, as compared to standard mouse sperm activation.
  • Investigators isolated sperm and processed half with the Ohana sperm cell treatment and half with standard media for preparing mouse sperm for IVF.
  • This confirms earlier observations that the Ohana sperm cell treatment has impacts beyond fertilization and may improve embryo development for people undergoing IVF with ICSI.

Assisted Reproductive Technology (ART) Market Size Worth USD 50.32 Billion by 2027 | CAGR of 9.3%: Emergen Research

Retrieved on: 
Monday, October 19, 2020
Fertility medicine, Articles, Human reproduction, Sexual reproduction, Assisted reproductive technology, Infertility, Insemination, Intracytoplasmic sperm injection, In vitro fertilisation, Artificial insemination, Reproductive technology

- Growing awareness and social adoption of assisted reproductive technology are among the significant factors influencing the assisted reproductive technology market growth.

Key Points: 
  • - Growing awareness and social adoption of assisted reproductive technology are among the significant factors influencing the assisted reproductive technology market growth.
  • - Market Size USD 24.62 Billion in 2019, Market Growth - CAGR of 9.3%, Market Trends Surge in infertility rate
    VANCOUVER, BC, Oct. 19, 2020 /PRNewswire/ -- The Global Assisted Reproductive Technology Market is projected to be worth USD 50.32 Billion by 2027, according to a new report by Emergen Research.
  • The market for assisted reproductive technology (ART) is experiencing rapid growth attributed to the surging popularity of in-vitro fertilization (IVF) (with or without Intracytoplasmic Sperm Injection (ICSI)) and artificial insemination-intrauterine (AI-IUI), among other technologies.
  • To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/assistive-reproductive-t...
    Emergen Research has segmented the Global Assisted Reproductive Technology (ART) Market on the basis of procedure, technology, end-user, and region:

Assisted Reproductive Technology (ART) Market Size Worth USD 50.32 Billion by 2027 | CAGR of 9.3%: Emergen Research

Retrieved on: 
Monday, October 19, 2020
Fertility medicine, Articles, Human reproduction, Sexual reproduction, Infertility, Assisted reproductive technology, Insemination, Intracytoplasmic sperm injection, In vitro fertilisation, Artificial insemination, Reproductive technology

VANCOUVER, BC, Oct. 19, 2020 /PRNewswire/ -- The Global Assisted Reproductive Technology Market is projected to be worth USD 50.32 Billion by 2027, according to a new report by Emergen Research.

Key Points: 
  • VANCOUVER, BC, Oct. 19, 2020 /PRNewswire/ -- The Global Assisted Reproductive Technology Market is projected to be worth USD 50.32 Billion by 2027, according to a new report by Emergen Research.
  • The market for assisted reproductive technology (ART) is experiencing rapid growth attributed to the surging popularity of in-vitro fertilization (IVF) (with or without Intracytoplasmic Sperm Injection (ICSI)) and artificial insemination-intrauterine (AI-IUI), among other technologies.
  • A significant cause of infertility in the worldwide population is sexually transmitted diseases (STDs), predominantly gonorrhea and chlamydia, which, in turn, would boost the growth of the assisted reproductive technology market.
  • To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/assistive-reproductive-t...
    Emergen Research has segmented the Global Assisted Reproductive Technology (ART) Market on the basis of procedure, technology, end-user, and region:

Ohana Biosciences Completes Enrollment in the SPRING Clinical Trial for Spertility, a Novel Sperm Cell Treatment to Improve Outcomes in Assisted Reproductive Technology

Retrieved on: 
Tuesday, September 22, 2020
Other Health, MEN, General Health, Consumer, Medical devices, Other Consumer, Clinical trials, Baby, Maternity, Women, Biotechnology, Alternative medicine, Health, Human reproduction, Articles, Fertility medicine, Sexual reproduction, In vitro fertilisation, Assisted reproductive technology, Reproductive technology, Embryo, Intracytoplasmic sperm injection, Sperm bank

Spertility is a sperm cell treatment designed to improve outcomes for people using Assisted Reproductive Technology (ART), such as In-Vitro Fertilization (IVF).

Key Points: 
  • Spertility is a sperm cell treatment designed to improve outcomes for people using Assisted Reproductive Technology (ART), such as In-Vitro Fertilization (IVF).
  • Completing enrollment in our initial clinical study of Spertility represents a significant milestone for our first product and Ohana.
  • Spertility offers the potential to be the first significant medical advance focused on sperm in ART in nearly 30 years.
  • Spertility is a patent-protected, ex vivo sperm cell treatment that in animal studies shows higher quality embryos and improves pregnancy outcomes.

Global Assisted Reproductive Technology Market 2020-2024 | Evolving Opportunities with Anecova SA and CRITEX GmbH | Technavio

Retrieved on: 
Tuesday, March 24, 2020
Science, Women, Other Science, Research, MEN, General Health, Health, Consumer, Fertility medicine, Human reproduction, Articles, Sexual reproduction, Reproductive technology, Assisted reproductive technology, Intracytoplasmic sperm injection, Infertility, In vitro fertilisation, Intracytoplasmic morphologically selected sperm injection, Annexin A3

In addition, the increase in awareness of ART is anticipated to boost the growth of the assisted reproductive technology market.

Key Points: 
  • In addition, the increase in awareness of ART is anticipated to boost the growth of the assisted reproductive technology market.
  • Consequently, the demand for assisted reproductive technology is increasing as it involves procedures such as intracytoplasmic sperm injection and vitro fertilization to address infertility.
  • Major Five Assisted Reproductive Technology Market Companies:
    Anecova SA generates revenue by the sale of a porous capsule, AneVivo device, which is used for providing assisted reproductive technology (ART) treatment.
  • Assisted Reproductive Technology Market Application Outlook (Revenue, USD Billion, 2020-2024)

Growth Insights on the US In Vitro Fertilization Services Market, 2018-2023

Retrieved on: 
Monday, November 25, 2019
Fertility medicine, Human reproduction, Sexual reproduction, Articles, Fertility, Zygote intrafallopian transfer, Human pregnancy, Assisted reproductive technology, Gamete intrafallopian transfer, In vitro fertilisation, Intracytoplasmic sperm injection, Infertility

DUBLIN, Nov. 25, 2019 /PRNewswire/ -- The "Growth Insights on the US In Vitro Fertilization Services Market, 2018" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 25, 2019 /PRNewswire/ -- The "Growth Insights on the US In Vitro Fertilization Services Market, 2018" report has been added to ResearchAndMarkets.com's offering.
  • The research service provides an overview of the US IVF Services Market and provides a 5-year forecast from 2018 to 2023.
  • The total fertility market is segmented into assisted reproductive technology (ART) services and fertility medications.
  • ART services comprise in vitro fertilization (IVF), Intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT).